Skip to main content
. 2014 Apr 14;99(7):E1154–E1162. doi: 10.1210/jc.2013-3248

Table 2.

Blood Hormone and Substrate Concentrations

Glucose, mg/dL Insulin, μU/mL Glucagon, pg/mL Lactate, mmol/L Glycerol, μmol/L FFAs, μmol/L
Isotope equilibrium
    NGT 94 ± 1.2a 15 ± 1.4 52 ± 2.5 0.46 ± 0.04 96 ± 11 496 ± 32
    IFG 103 ± 1.6 19 ± 1.4 61 ± 3.9 0.47 ± 0.04 105 ± 10 564 ± 33
Euglycemia
    NGT 89 ± 2.2 38 ± 2.8b 78 ± 2.5b 0.42 ± 0.02 40 ± 3.4a,b 80 ± 13b
    IFG 87 ± 2.1b 43 ± 3.8b 78 ± 3.0b 0.42 ± 0.03 51 ± 4.4b 100 ± 13b
Hyperglycemia
    NGT 177 ± 3b 42 ± 3.6 73 ± 2.3 0.48 ± 0.03 38 ± 3.6a 54 ± 9.0
    IFG 175 ± 2b 48 ± 4.4 73 ± 3.2 0.47 ± 0.02 56 ± 6.9 65 ± 8.3b
Hyperglycemia+fructose
    NGT 178 ± 2 44 ± 3.7 70 ± 2.4 0.56 ± 0.03 36 ± 2.9a 43 ± 7.3
    IFG 178 ± 3 48 ± 4.3 74 ± 2.8 0.53 ± 0.03 50 ± 6.0 58 ± 6.1

Values are mean ± SEM.

a

P < .05, NGT vs IFG.

b

P < .05 compared with prior stage.